$3.2M DEA Settlement Should Caution Hospitals on Controlled-Substance Recordkeeping

The DEA reached a $3.2 million settlement with Sutter Medical Center, Sacramento and Sutter Fairfield Surgery Center to resolve 628 alleged violations of Controlled Substances Act recordkeeping and security requirements. SMCS faced 360 violations including failures to link CSOS records and notify DEA of theft/loss; SFSC faced 268 violations spanning recordkeeping, inventory, and security failures. The settlement underscores federal enforcement focus on holding healthcare providers accountable for safeguarding controlled substances against theft and diversion.

Xendit Trademark Published for Opposition - Class 36 Financial Services

The USPTO published Xendit's Class 36 trademark application (TM79438973) for opposition, covering financial services including payment gateway, payment processing, digital wallet services, cryptocurrency transactions, and electronic fund transfer services. The publication initiates a standard opposition period during which third parties may challenge the registration.

Honda Machine Learning Method for Bird's-Eye View 3D Object Detection

USPTO granted Honda Motor Co., Ltd. Patent US12597277B2 covering a machine learning method for three-dimensional object detection using bird's-eye view images. The patent describes associating annotations with extended areas in bird's-eye view images and training models to identify 3D objects. The patent contains 12 claims and was granted to inventors Yuji Yasui, Hideki Matsunaga, Takashi Matsumoto, and Gakuyo Fujimoto.

Controlling an alert signal for spectral computed tomography imaging

USPTO granted patent US12597139B2 to Koninklijke Philips N.V. covering a machine-learning method for spectral CT imaging that identifies areas of clinical relevance not visible in non-spectral CT data. The patent compares predicted spectral CT image data with actual spectral CT data to control alert signals for clinicians. The patent includes 15 claims and covers neural network-based processing of medical imaging data.

CD133-binding agents and uses thereof

The USPTO granted patent US12595312B2 to the University of Toronto covering novel CD133-binding agents for detecting and targeting CD133-expressing cancer cells, quantitating cellular CD133 expression levels, and treating or preventing cancer. The patent names 9 inventors including Jason Moffat, Jarrett Adams, and Sachdev Sidhu, with 27 claims. The patent application was filed October 26, 2021 under CPC classification A61K 2039/505.

Chitosan-based beads, preparation, compositions and uses thereof

KIOMED PHARMA has been granted USPTO Patent US12595342B2 for chitosan-based beads comprising a hydrogel matrix with carboxyalkyl chitosan. The patent contains 41 claims covering the composition, preparation methods, and pharmaceutical applications of the technology.

Method for producing maleimide polyethylene glycol derivative

The USPTO granted patent US12595336B2 to NOF Corporation on April 7, 2026, covering a method for producing maleimide polyethylene glycol (PEG) derivatives via silica-gel-assisted deprotection. The patent, with 6 claims, names inventors Daiki Ozone, Shota Mori, and Masaki Ota. Maleimide PEG derivatives are widely used as drug linkers and conjugate modifiers in biopharmaceutical formulations.

Blockchain Stablecoin System for SEC-Qualified Digital Transactions

USPTO granted Patent US12597000B2 to Ceres Coin LLC covering a blockchain stablecoin system that uses an SEC-qualified stablecoin as a store of value and medium of exchange on a blockchain transaction network. The patent includes 20 claims relating to stablecoin blockchain frameworks, ecosystems, and distributed ledger transaction networks for regulated industries.

System and method for converting cryptocurrency to virtual assets

USPTO granted patent US12596999B2 to Uphold Global Foundation on April 7, 2026, covering a computer-based system that converts cryptocurrency into virtual assets whose value is substantiated by a reserve of assets. The system includes user account database, cryptocurrency account, and user interface servers configured to manage transfers and conversion requests. The patent contains 16 claims.

No-code Generation of Integration Applications via Natural Language

The USPTO granted Patent US12596991B2 to Salesforce, Inc. covering systems and methods for programmatically generating and deploying integration applications based on natural language requests without requiring user coding. The patent discloses an application generator that infers sources, targets, connectors, operations, entities, and data mappings from natural language input via an exposed web service or API. The patent contains 20 claims and was filed on June 8, 2023.